C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 401/12 (2006.01) A61K 31/415 (2006.01) A61P 11/00 (2006.01) A61P 29/00 (2006.01)
Patent
CA 2754609
The present invention relates to a compound of formula (I): or a pharmaceutically acceptable salt thereof, including all stereoisomers and tautomers, which is an inhibitor of p38 mitogen- activated protein kinase enzymes(referred to herein as p38 MAP kinase inhibitors), particularly the alpha and gamma kinase sub-types thereof, and itsuse in therapy, including in pharmaceu-tical combinations, especially in the treatment of inflammatory diseases, including inflammatory diseases of the lung, such as COPD.
La présente invention porte sur un composé de formule (I) : ou sur un sel pharmaceutiquement acceptable de celui-ci, comprenant l'ensemble des stéréoisomères et tautomères, qui est un inhibiteur des enzymes kinases p38 de protéines activées par le mitogène (désigné présentement comme inhibiteur de p38 MAP kinase), en particulier de leurs sous-types alpha et gamma kinase, et sur son utilisation en thérapie, comprenant des compositions pharmaceutiques, notamment dans le traitement de maladies inflammatoires, comprenant des maladies inflammatoires du poumon, telles qu'une maladie pulmonaire obstructive chronique (COPD).
Charron Catherine Elisabeth
Ito Kazuhiro
King-Underwood John
Murray Peter John
Onions Stuart Thomas
Gowling Lafleur Henderson Llp
Respivert Limited
LandOfFree
P38map kinase inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with P38map kinase inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and P38map kinase inhibitor will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2090123